Taiwan FDA registration 2fdc8b7ffe45950ca0174c5350fbcf22

Nofafer Human Antimeasles Virus Immunoglobulin G Enzyme Immunoassay Kit (Unsterilized)

TW: 諾法鐵人類抗麻疹病毒免疫球蛋白G酵素免疫分析套組（未滅菌）

Taiwan·Risk Class 1·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Mar 16, 2006 – Mar 16, 2026Expired

Registration details

Analysis ID: 2fdc8b7ffe45950ca0174c5350fbcf22
Customs Code: DHA04400297801

Company information

Manufacturer: GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
Manufacturer Country: Germany
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Qualitative detection of anti-measles virus immunoglobulin G antibodies in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3520 麻疹病毒血清試劑
Import Information: import

Dates and status

Registration Date: Mar 16, 2006
Expiry Date: Mar 16, 2026

About this record

Access comprehensive regulatory information for Nofafer Human Antimeasles Virus Immunoglobulin G Enzyme Immunoassay Kit (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2fdc8b7ffe45950ca0174c5350fbcf22 and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.